GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 204 Consolidated Balance Sheet as at March 31, 2022 ( ` in lakhs ) Notes As at March 31, 2022 As at March 31, 2021 ASSETS Non-current assets Property, plant and equipment 3 277,37.03 310,93.21 Right of use assets 48 17,57.48 31,26.43 Capital work-in-progress 3 30,50.21 13,21.43 Investment property 4 1,20.57 1,34.95 Intangible assets 5 34,49.74 43,36.40 Financial assets (i) Loans 6 190,00.00 - (ii) Other financial assets 7 11,06.29 12,09.00 Current tax assets (net) 47 197,60.40 346,50.01 Deferred tax assets (net) 47 113,14.81 103,12.61 Other non-current assets 8 52,28.02 50,16.72 925,24.55 912,00.76 Current assets Inventories 9 534,69.54 546,69.81 Financial assets (i) Current Investments 10 365,59.23 - (ii) Trade receivables 11 205,23.89 215,60.46 (iii) Cash and cash equivalents 12 286,18.71 405,18.92 (iv) Bank balances other than (iii) above 13 2198,32.07 752,77.48 (v) Other financial assets 14 71,84.72 25,71.60 Other current assets 15 46,03.84 76,53.87 3707,92.00 2022,52.14 Assets classified as held for sale 16 11.23 180,11.84 3708,03.23 2202,63.98 TOTAL ASSETS 4633,27.78 3114,64.74 EQUITY AND LIABILITIES EQUITY Equity share capital 17 169,40.60 169,40.60 Other equity 18 2493,54.98 1308,85.39 Total equity 2662,95.58 1478,25.99 LIABILITIES Non-current liabilities Financial liabilities (i) Lease liabilities 19 & 48 7,62.35 20,24.99 (ii) Other financial liabilities 20 2,05.81 2,05.81 Provisions 21 & 28 262,21.16 259,49.88 271,89.32 281,80.68 Current liabilities Financial liabilities (i) Borrowings 22 - 2.40 (ii) Lease liabilities 23 & 48 12,45.30 14,35.27 (iii) Trade payables 24 Total outstanding dues of micro enterprises and small enterprises 7,92.72 5,26.94 Total outstanding dues of creditors other than micro enterprises and small enterprises 562,62.15 460,86.05 (iv) Other financial liabilities 25 133,50.57 171,87.83 Other current liabilities 26 357,73.91 263,85.05 Provisions 27 & 28 327,97.88 274,62.27 Current tax liabilities (net) 47 296,20.35 163,72.26 1698,42.88 1354,58.07 Total liabilities 1970,32.20 1636,38.75 TOTAL EQUITY AND LIABILITIES 4633,27.78 3114,64.74 The accompanying notes 1 to 64 are an integral part of the Consolidated Financial Statements In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants R. S. Karnad Chairperson DIN: 00008064 Firm‘s Registration No. 117366W/W-100018 S. Venkatesh Managing Director DIN: 07263117 J. Chandy CFO & Whole-time Director DIN: 09530618 Rupen K. Bhatt D. Sundaram Audit Committee Chairman DIN: 00016304 Partner A. Nadkarni Company Secretary FCS 10460 Membership No. 046930 Mumbai, May 16, 2022 Mumbai, May 16, 2022